Unknown NA INTERVENTIONAL 1-arm NCT01280214

Local Triamcinolone Injection in Active Thyroid Orbitopathy

Peribulbar and Subconjunctival Kenalog Injection for Thyroid Orbitopathy

Sponsor: HaEmek Medical Center, Israel

Updated 5 times since 2017 Last updated: Jan 19, 2011 Started: Feb 28, 2011 Primary completion: Feb 28, 2013 Completion: Feb 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Thyroid Disease and is currently ongoing. HaEmek Medical Center, Israel leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

HaEmek Medical Center, Israel

Data source: HaEmek Medical Center, Israel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.